ipscell.com
J&J Bets Up to $325 million on Capricor: Big Pharma Stem Cell Move as Predicted for 2014 - The Niche
Big Pharma Giant Johnson & Johnson (J & J; $JNJ) announced today a $12.5 million investment in stem cells & regenerative medicine via the small biotech Capricor ($CAPR) and the potential for the bet to go into the hundreds of millions for the heart disease program. It was only 8 days ago that I made … J&J Bets Up to $325 million on Capricor: Big Pharma Stem Cell Move as Predicted for 2014 Read More »
Professor Paul Knoepfler, Ph.D.